Work

Extrapulmonary small cell carcinoma treated with conventional or tumor-targeted topoisomerase I inhibition plus ATR blockade: Clinical outcomes and molecular correlates.

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.3027

Authors: Chirayu Mohindroo, Nobuyuki Takahashi, Rajesh Kumar, Samantha Nichols, Linda Sciuto, Danielle Pinkiert, Tristan M. Sissung, Elaine Shum, Liza C. Villaruz, Jonathan W. Riess, Jorge J. Nieva, Hirva Mamdani, William J. Petty, Aman Chauhan, W Douglas Figg, Zhonglin Hao, Anish Thomas

Institutions: National Institutes of Health, National Cancer Institute, National Cancer Center Hospital East, Center for Cancer Research, NYU Langone Health, University of Pittsburgh Medical Center, UC Davis Comprehensive Cancer Center, University of Southern California, USC Norris Comprehensive Cancer Center, Wayne State University, The Barbara Ann Karmanos Cancer Institute, Wake Forest University, UCSF Helen Diller Family Comprehensive Cancer Center, University of Kentucky

Language: English

Topic: Neuroendocrine Tumor Research Advances

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7162515224

Cites:

Cited by:

Related to: